Thursday, October 25, 2018

Amgen Slashes the Price of a Promising Cholesterol Drug by KATIE THOMAS


By KATIE THOMAS

The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.

Published: October 24, 2018 at 08:00PM

from NYT Health https://ift.tt/2Sj05PK
via IFTTT



from WordPress https://ift.tt/2OParsw
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)